Pentoxifylline in Acute Nonhemorrhagic Stroke


Phase 2 Results


Neurologic deficit scores improved from baseline admission scores during the 4-week study in both groups but did not differ between groups at admission or throughout the study except during the first few days. There were no differences in mortality of functional deficit between treatment groups.